The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

In a recent study published in the Journal of Cystic Fibrosis, Don Ingber and his group at the Wyss Institute of Biologically ... In 2010, his team created the first lung-on-a-chip, a small in vitro ...

The new data from the 1,178-patient FIBRONEER-ILD study showed that the oral PDE 4B inhibitor was able to improve lung function in patients with progressive pulmonary fibrosis (PPF), a form of ...

The team revealed distinct phases where waves of immune responses give way to lung fibrosis—scarring of the lungs—in severe COVID-19. As part of the UK Coronavirus Immunology Consortium (UK ...

Please provide your email address to receive an email when new articles are posted on . Researchers captured exercise capacity measures during the first week of pulmonary rehabilitation to the ...

In the early stages, symptoms may be mild. An abnormal chest X-ray may be the first sign of a problem. Silicosis is a type of lung disease that causes irreversible lung inflammation and fibrosis.